健康与疾病中的神经肽受体：体内成像的分子基础 - Suppr

Suppr

超能文献

Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.

作者信息

Reubi J C

机构信息

Division of Cell Biology and Experimental Cancer Research, University of Berne, Switzerland.

出版信息

J Nucl Med. 1995 Oct;36(10):1825-35.

PMID:7562050

Abstract

摘要

相似文献

Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.健康与疾病中的神经肽受体：体内成像的分子基础

J Nucl Med. 1995 Oct;36(10):1825-35.

In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging.

J Nucl Med. 1995 Oct;36(10):1846-53.

Mack Forster Award Lecture. Receptor nuclear medicine: vasointestinal peptide and somatostatin receptor scintigraphy for diagnosis and treatment of tumour patients.麦克·福斯特奖讲座。受体核医学：用于肿瘤患者诊断和治疗的血管活性肠肽及生长抑素受体闪烁显像

Eur J Clin Invest. 1997 Oct;27(10):793-800. doi: 10.1046/j.1365-2362.1997.1990742.x.

Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.人类间充质肿瘤中的生长抑素和血管活性肠肽受体：体外鉴定

Cancer Res. 1996 Apr 15;56(8):1922-31.

Imaging tumors with peptide-based radioligands.使用基于肽的放射性配体对肿瘤进行成像。

Q J Nucl Med. 2001 Jun;45(2):189-200.

Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs.血管活性肠肽、生长抑素和P物质受体在人淋巴器官不同区域的定位。

Blood. 1998 Jul 1;92(1):191-7.

Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy.

Q J Nucl Med. 1997 Jun;41(2):63-70.

Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.

N Engl J Med. 1994 Oct 27;331(17):1116-21. doi: 10.1056/NEJM199410273311703.

Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.血管活性肠肽和生长抑素受体闪烁扫描术用于肝类癌转移的鉴别诊断

J Nucl Med. 1997 Jun;38(6):880-1.

Receptors for pituitary adenylate cyclase-activating peptide in human liver.人类肝脏中垂体腺苷酸环化酶激活肽的受体

J Clin Endocrinol Metab. 1995 Aug;80(8):2451-7. doi: 10.1210/jcem.80.8.7629241.

引用本文的文献

[Ga]-DOTATOC PET/CT Volumetric Parameters Reflect Metastatic Potential in Pancreatic Neuroendocrine Tumors.[镓]-DOTATOC PET/CT体积参数反映胰腺神经内分泌肿瘤的转移潜能

Cancers (Basel). 2025 Apr 28;17(9):1487. doi: 10.3390/cancers17091487.

Current and upcoming radionuclide therapies in the direction of precision oncology: A narrative review.精准肿瘤学方向上的当前及未来放射性核素疗法：一篇叙述性综述。

Eur J Radiol Open. 2023 Jan 31;10:100477. doi: 10.1016/j.ejro.2023.100477. eCollection 2023.

Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors.胃肠胰神经内分泌肿瘤靶向肽受体放射性核素正电子发射断层成像与治疗的现状与未来。

World J Gastroenterol. 2022 May 7;28(17):1768-1780. doi: 10.3748/wjg.v28.i17.1768.

Prospective Within-Patient Assessment of the Impact of an Unlabeled Octreotide Pre-dose on the Biodistribution and Tumor Uptake of Ga DOTATOC as Assessed by Dynamic Whole-body PET in Patients with Neuroendocrine Tumors: Implications for Diagnosis and Therapy.前瞻性患者内评估未标记的奥曲肽预给药对神经内分泌肿瘤患者动态全身PET评估的镓[68Ga] DOTATOC生物分布和肿瘤摄取的影响：对诊断和治疗的意义

Mol Imaging Biol. 2021 Oct;23(5):766-774. doi: 10.1007/s11307-021-01600-5. Epub 2021 Apr 7.

Preparation, Characterization, and Radiolabeling of [Ga]Ga-NODAGA-Pamidronic Acid: A Potential PET Bone Imaging Agent.[Ga]Ga-NODAGA-帕米膦酸的制备、表征及放射性标记：一种潜在的 PET 骨显像剂。

Molecules. 2020 Jun 9;25(11):2668. doi: 10.3390/molecules25112668.

Targeting VPAC1 Receptors for Imaging Glioblastoma.针对脑胶质瘤的 VPAC1 受体成像。

Mol Imaging Biol. 2020 Apr;22(2):293-302. doi: 10.1007/s11307-019-01388-5.

Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics.评估用于靶向 VPAC 受体的 Ga-68 肽缀合物：稳定性和药代动力学。

Mol Imaging Biol. 2019 Feb;21(1):130-139. doi: 10.1007/s11307-018-1207-x.

Evaluation of a PACAP Peptide Analogue Labeled with (68)Ga Using Two Different Chelating Agents.使用两种不同螯合剂对用（68）Ga标记的垂体腺苷酸环化酶激活肽（PACAP）肽类似物的评估。

Cancer Biother Radiopharm. 2016 Feb;31(1):29-36. doi: 10.1089/cbr.2015.1947.

Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5.近红外荧光标记的δ-阿片受体拮抗剂Dmt-Tic-Cy5的肿瘤靶向性和药代动力学

Mol Pharm. 2016 Feb 1;13(2):534-44. doi: 10.1021/acs.molpharmaceut.5b00760. Epub 2016 Jan 8.

Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer.神经降压素分支肽作为一种针对人类膀胱癌的肿瘤靶向剂。

Biomed Res Int. 2015;2015:173507. doi: 10.1155/2015/173507. Epub 2015 Apr 23.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验